Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06182592
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-28
First Post:
2023-12-13
Brief Title:
A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk Secondary Acute Myeloid Leukemia
Sponsor:
Organization:
CSPC Zhongnuo Pharmaceutical Shijiazhuang Co Ltd